Cellectis CLLS Institutional Ownership

Cellectis S.A. (NASDAQ:CLLS) has 27 institutional investors with active 13F positions as of June 2026.

• Their combined ownership stood at 9.5% of outstanding shares in June 2026, down from 10.2% in March 2026.
• They decreased total shares held in Cellectis by -6.64% from the prior quarter, while the number of investors in CLLS increased 12.5% year over year.
• Activity in CLLS broke down as 5 buyers, 10 sellers, and 12 unchanged among 27 total holders.
• The aggregate institutional position in Cellectis amounted to 9.48Mn shares as of June 2026, down by 673.98K shares quarter on quarter, and down 2.19Mn shares year over year.
• As of June 30, 2026, B Group, Inc. held the largest stake in Cellectis with 3.28Mn shares, accounting for 3.27% of total shares outstanding.
• The biggest buyers of Cellectis for the quarter ending June 2026 included UBS Group AG (4.15K), Royal Bank Of Canada (1.56K), LPL Financial LLC (70), JONES FINANCIAL COMPANIES LLLP (50), Caitong International Asset Management Co., Ltd (49).
• Leading sellers of Cellectis shares for the quarter ending June 2026 were UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (533.74K), BlackRock, Inc. (116.08K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (15.49K), EverSource Wealth Advisors, LLC (5.07K), XTX Topco Ltd (3.99K).
• According to Business Quant data, leading holders of CLLS for June 2026 are B Group, Inc. (3.28Mn), Long Focus Capital Management, LLC (2.74Mn), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (2.64Mn), NOMURA ASSET MANAGEMENT INTERNATIONAL INC. (226.88K), BlackRock, Inc. (225.44K), Morgan Stanley (85.46K), LPL Financial LLC (84.42K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (50.45K), BNP PARIBAS FINANCIAL MARKETS (40.1K), UBS Group AG (33.93K).